Anterix Inc. Files 8-K: Officer/Director Changes & More
Ticker: ATEX · Form: 8-K · Filed: Sep 18, 2025 · CIK: 1304492
Sentiment: neutral
Topics: corporate-governance, officer-changes, director-changes
TL;DR
Anterix leadership shuffle and compensation details filed today.
AI Summary
Anterix Inc. filed an 8-K on September 18, 2025, reporting on the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements. The filing also includes Regulation FD disclosures and financial statements and exhibits.
Why It Matters
This filing provides crucial updates on the company's leadership and governance structure, which can impact strategic direction and investor confidence.
Risk Assessment
Risk Level: medium — Changes in key personnel and compensatory arrangements can signal shifts in company strategy or financial health, requiring investor attention.
Key Players & Entities
- Anterix Inc. (company) — Registrant
- September 18, 2025 (date) — Date of earliest event reported
FAQ
Who has departed from Anterix Inc.'s board or officer positions?
The filing indicates the departure of directors or certain officers, but specific names are not detailed in the provided text.
Were new directors or officers elected or appointed?
Yes, the filing explicitly mentions the election of directors and the appointment of certain officers.
What is the nature of the compensatory arrangements disclosed?
The filing covers compensatory arrangements of certain officers, though specific details are not provided in this excerpt.
What other items are covered in this 8-K filing?
In addition to personnel and compensation matters, the filing includes Regulation FD disclosures and financial statements and exhibits.
What is Anterix Inc.'s fiscal year end?
Anterix Inc.'s fiscal year ends on March 31.
Filing Stats: 946 words · 4 min read · ~3 pages · Grade level 11.5 · Accepted 2025-09-18 07:27:43
Key Financial Figures
- $0.0001 — ange on which registered Common Stock, $0.0001 par value ATEX The Nasdaq Stock Market
- $250,000.00 — h an aggregate grant date fair value of $250,000.00 under the Company's 2023 Stock Plan, wi
Filing Documents
- atex-20250918.htm (8-K) — 34KB
- anterixpressrelease-change.htm (EX-99.1) — 12KB
- capturea.jpg (GRAPHIC) — 10KB
- 0001304492-25-000099.txt ( ) — 176KB
- atex-20250918.xsd (EX-101.SCH) — 2KB
- atex-20250918_lab.xml (EX-101.LAB) — 22KB
- atex-20250918_pre.xml (EX-101.PRE) — 13KB
- atex-20250918_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure On September 18, 2025, the Company issued a press release in connection with the Chief Financial Officer transition. A copy of the press release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Current Report on Form 8-K furnished under this Item 7.01 shall not be deemed "filed" for any purpose, including for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section. Furthermore, the information in this Current Report on Form 8-K furnished under this Item 7.01 shall not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act regardless of any general incorporation language in such filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release dated September 18, 2025. 104 Cover Page Interactive Data File (formatted as Inline XBRL).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. Anterix Inc. Date: September 18, 2025 /s/ Gena L. Ashe Gena L. Ashe Chief Legal Officer and Corporate Secretary